Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-02-03

FDA Approved: LITHIUM CARBONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's original ANDA for lithium carbonate, making the generic mood stabilizer available for use in bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

ORIG AP for LITHIUM CARBONATE (LITHIUM CARBONATE)